NCT03521050 LUKS-Leads Registry on Long-term Performance of ICD Leads
| NCT ID | NCT03521050 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Luzerner Kantonsspital |
| Condition | Defibrillators |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2016-12 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2016-12 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
All patients having an implantable cardiac defibrillator (ICD) implanted and having follow-up at the Cantonal Hospital Lucerne (LUKS), the investigator center, are included in this retrospective ICD lead registry from 2006 onwards. Data is collected prospectively from december 2016 onwards. After certain ICD-leads tended to fail early the investigators aimed for a registry monitoring our patient population with defibrillator leads and evaluating their long-term performance.
Eligibility Criteria
Inclusion Criteria: * all patients being implanted with a Defibrillator lead from 2006 onwards Exclusion Criteria: * documented refusal of data collection for scientific purposes
Contact & Investigator
Richard Kobza, MD
PRINCIPAL INVESTIGATOR
Luzerner Kantonsspital
Frequently Asked Questions
Who can join the NCT03521050 clinical trial?
This trial is open to participants of all sexes, studying Defibrillators. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03521050 currently recruiting?
Yes, NCT03521050 is actively recruiting participants. Contact the research team at richard.kobza@luks.ch for enrollment information.
Where is the NCT03521050 trial being conducted?
This trial is being conducted at Lucerne, Switzerland.
Who is sponsoring the NCT03521050 clinical trial?
NCT03521050 is sponsored by Luzerner Kantonsspital. The principal investigator is Richard Kobza, MD at Luzerner Kantonsspital. The trial plans to enroll 1,000 participants.